210 related articles for article (PubMed ID: 23370301)
1. Anti-inflammatory activity of a naphthyridine derivative (7-chloro-6-fluoro-N-(2-hydroxy-3-oxo-1-phenyl-3-(phenylamino)propyl)-4-oxo-1-(prop-2-yn-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide) possessing in vitro anticancer potential.
Madaan A; Kumar V; Verma R; Singh AT; Jain SK; Jaggi M
Int Immunopharmacol; 2013 Mar; 15(3):606-13. PubMed ID: 23370301
[TBL] [Abstract][Full Text] [Related]
2. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
[TBL] [Abstract][Full Text] [Related]
3. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
[TBL] [Abstract][Full Text] [Related]
4. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
[TBL] [Abstract][Full Text] [Related]
6. 1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivative.
Di Braccio M; Grossi G; Alfei S; Ballabeni V; Tognolini M; Flammini L; Giorgio C; Bertoni S; Barocelli E
Eur J Med Chem; 2014 Oct; 86():394-405. PubMed ID: 25194932
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel derivatives of murrayafoline A and their inhibitory effect on LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
Thuy TT; Cuong NM; Toan TQ; Thang NN; Tai BH; Nhiem NX; Hong HJ; Kim S; Legoupy S; Koh YS; Kim YH
Arch Pharm Res; 2013 Jul; 36(7):832-9. PubMed ID: 23564015
[TBL] [Abstract][Full Text] [Related]
8. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
Józefowski S; Bobek M; Marcinkiewicz J
Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory aminoacetylenic isoindoline-1,3-dione derivatives modulate cytokines production from different spleen cell populations.
Matalka KZ; Alfarhoud F; Qinna NA; Mallah EM; Abu-Dayyih WA; Muhi-eldeen ZA
Int Immunopharmacol; 2012 Nov; 14(3):296-301. PubMed ID: 22884510
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
Tsuzuki Y; Tomita K; Sato Y; Kashimoto S; Chiba K
Bioorg Med Chem Lett; 2004 Jun; 14(12):3189-93. PubMed ID: 15149673
[TBL] [Abstract][Full Text] [Related]
11. A supercritical CO₂ extract from seabuckthorn leaves inhibits pro-inflammatory mediators via inhibition of mitogen activated protein kinase p38 and transcription factor nuclear factor-κB.
Jayashankar B; Mishra KP; Kumar MS; Udayasankar K; Misra K; Ganju L; Singh SB
Int Immunopharmacol; 2012 Aug; 13(4):461-7. PubMed ID: 22664145
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of oleanane-type triterpenes and saponins from the stem bark of Kalopanax pictus on LPS-stimulated pro-inflammatory cytokine production in bone marrow-derived dendritic cells.
Quang TH; Ngan NT; Van Minh C; Van Kiem P; Nhiem NX; Tai BH; Thao NP; Chae D; Mathema VB; Koh YS; Lee JH; Yang SY; Kim YH
Arch Pharm Res; 2013 Mar; 36(3):327-34. PubMed ID: 23444041
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides].
Di Braccio M; Roma G; Balbi A; Sottofattori E; Carazzone M
Farmaco; 1989 Sep; 44(9):865-81. PubMed ID: 2604838
[TBL] [Abstract][Full Text] [Related]
14. Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study.
Shieh JH; Peterson RH; Moore MA
J Immunol; 1994 Jan; 152(2):859-66. PubMed ID: 8283056
[TBL] [Abstract][Full Text] [Related]
15. Antithetical effects of hemicellulase-treated Agaricus blazei on the maturation of murine bone-marrow-derived dendritic cells.
Kawamura M; Kasai H; He L; Deng X; Yamashita A; Terunuma H; Horiuchi I; Tanabe F; Ito M
Immunology; 2005 Mar; 114(3):397-409. PubMed ID: 15720441
[TBL] [Abstract][Full Text] [Related]
16. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.
Ruggiero V; Piovesan P; Fabrizi C; Lauro GM; Campo S; Albertoni C; Nucera E; Carminati P; Ghirardi O
Shock; 2004 Jan; 21(1):77-85. PubMed ID: 14676688
[TBL] [Abstract][Full Text] [Related]
18. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-κB signaling pathway.
Lu CN; Yuan ZG; Zhang XL; Yan R; Zhao YQ; Liao M; Chen JX
Int Immunopharmacol; 2012 Sep; 14(1):121-6. PubMed ID: 22728095
[TBL] [Abstract][Full Text] [Related]
19. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cell suppression by IL-1 receptor antagonist on retinal pigment epithelium cells.
Sugita S; Kawazoe Y; Imai A; Usui Y; Iwakura Y; Isoda K; Ito M; Mochizuki M
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3240-9. PubMed ID: 23532521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
